SNTI
Closed
Senti Biosciences Inc
2.19
+0.08 (+3.79%)
Last Update: 01 Jul 2025 23:00:00
Yesterday: 2.11
Day's Range: 2.15 - 2.2654
Send
sign up or login to leave a comment!
When Written:
1.09
Senti Biosciences Inc is a biotechnology company founded in 2016 that is focused on developing a new generation of gene circuit therapies. The company's technology platform is based on synthetic biology and gene editing, which allows for the precise control of gene expression and regulation. Senti's gene circuit therapies are designed to address a wide range of diseases, including cancer, autoimmune disorders, and genetic diseases. The company is headquartered in South San Francisco, California, and has partnerships with several leading pharmaceutical companies. Senti Biosciences has raised over $166 million in funding to date from investors such as NEA, 8VC, and Lux Capital.
Note: This message is generated by artificial intelligence; it does not guarantee the accuracy of the information it contains and should not be considered as investment advice.
Note: This message is generated by artificial intelligence; it does not guarantee the accuracy of the information it contains and should not be considered as investment advice.
(0)
(0)
Send
sign up or login to leave a comment!!








